Good MorningEquity markets tried to rebound on Thursday, but the move was weak and short-lived. The S&P 500 gained about a half percent at the session's high but closed the day with a loss of 0.35%. The move may turn into a deeper rout today following the NFP report. If it aligns with labor data released this week, it will reaffirm the idea that the FOMC will keep interest rates higher for longer. In this scenario, the FOMC is on track to cut rates in 2023, but when and why are yet to be seen. As it is, the first cuts aren't likely until later in the year.
Next week starts peak earnings season, but don't get too excited yet. The reports will come out in dribbles until Friday, when reports from the big banks are due. The general expectation is that banks generate solid profits due to higher interest rates and can sustain capital returns. The question is how the consumer is holding up. If the banks reveal a weakened or weakening consumer, the sell-off in equities could gain momentum regardless of bank earnings.
Featured: The "Scaled Selling Technique" Gives You Exact Profit Targets BEFORE You Enter Any New Trade (The Oxford Club) 
|
Markets | | |
You've probably heard of growth stocks before, but what is a growth stock mutual fund? When buying individual stocks, there's always the risk that a bad earnings report could significantly hurt the share price.
But that risk is mitigated when a basket of stocks is held, and growth stock mut... Read the Full Story |
|
From Our PartnersEverything is lining up perfectly for a historic gold bull run. One gold expert says he's found the best way to get in, for just $5. | | | | Click here for full details. |
|
Markets | | |
"Is Delta Air Lines stock a buy?" is a question frequently asked by investors.
Delta Air Lines is one of the world's largest airlines, and its stock has been relatively volatile in recent months. The company has benefited from a strong recovery in air travel, and its financial results have ... Read the Full Story |
|
Markets | | |
The aviation sector, marked by its susceptibility to economic fluctuations and global events, holds both promise and caution for investors. As the dust settles from the turbulence brought about by the COVID-19 pandemic, investors are eyeing American Airlines with a critical lens, evaluating whethe... Read the Full Story |
|
From Our PartnersAs you know, the stock market has been volatile lately, and there's a lot of uncertainty in the air. But we want to assure you that this is not the time to panic. In fact, it's the time to be buying stocks.
By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
| | | | Download Our Free Report Here |
|
Markets | | |
If you're like most investors, retirement is one of your major financial goals. However, the road toward retirement can often seem overwhelming and confusing — especially regarding the many types of retirement accounts you can use to invest. An individual retirement account (IRA) is a tax-ad... Read the Full Story |
|
Markets | | |
Coinbase Global Inc. (NASDAQ: COIN) is the largest publicly traded cryptocurrency exchange in the U.S. It is arguably the most trusted and stable exchange due to its regulatory transparency and liquidity. As a member of the financial services sector, Coinbase is considered the crypto exchange of c... Read the Full Story |
|
From Our PartnersThe AI sector is booming, potentially reaching $2 trillion by 2030. Have you positioned yourself to benefit? Our exclusive report on the hottest Top 5 AI Stocks provides you with insights not found elsewhere. | | Want in on the action? Get your FREE copy now. |
|
Markets | | | Wall Street closed its worst week since Halloween with a listless Friday after reports showed workers are getting bigger raises, but key parts of the economy still don’t look like they’re overheating. The S&P 500 rose 8.56 points, or 0.2%, to 4,697.24 after drifting between small gains and losse... Read the Full Story |
|
Markets | | | Asian shares mostly declined Friday, after a mixed finish on Wall Street, although export-related Tokyo stocks got a boost from a strengthening dollar. Benchmarks rose in Tokyo but fell in Sydney, Seoul, Hong Kong and Shanghai. The yen has weakened amid speculation that the Bank of Japan might go sl... Read the Full Story |
|
Markets | | | The United Nations has issued a somber global economic forecast for 2024, pointing to challenges from escalating conflicts, sluggish global trade, persistently high interest rates and increasing climate disasters Read the Full Story |
|
Markets | | | The nation’s employers added a robust 216,000 jobs last month, the latest sign that the American labor market remains resilient even in the face of sharply higher interest rates.Friday’s government report showed that December’s job gain exceeded the 173,000 that were added in November. The unemploym... Read the Full Story |
|
Markets | | | Carbon dioxide emissions in Germany, Europe's biggest economy, dropped to their lowest level in seven decades as the use of coal declined unexpectedly sharply in 2023 and economic pressures weighed down production by energy-intensive industry, according to a study released Thursday.Germany aims to c... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore. | | View Today's Stock Pick |
|
